Breast Cancer Therapeutics Market to Exhibit 10.2% CAGR, Increasing R&D Investment to Boost Growth, says Fortune Business Insights

NEXT STORY
Batavia Biosciences receives $2.2 million follow-up grant from PATH to support new tools for polio eradication era
PREV STORY
Contraceptive Devices Market to Reach US$ 11,166.4 Mn by 2025, Driven by Optimum Assurance Towards Safety Offered By These Devices, States Fortune Business Insights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

NexImmune Announces Management and Board Appointments

Scott Carmer appointed Chief Executive OfficerKristi Jones promoted to Chief Operating OfficerAlan Roemer appointed ...

author_avatar
NASDAQ Market News

Junshi Biosciences Announces Acceptance of a Supplemental NDA in China for Toripalimab in Advanced Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News

XBiotech Announces First Patient in Phase 2 Study Evaluating Subcutaneous MABp1 in Patients with Hidradenitis Suppurativa

AUSTIN, Texas, July 10, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that ...

author_avatar
NASDAQ Market News